These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 14379004)

  • 1. Poliomyelitis Lansing antibodies in three population groups in Israel.
    BERNKOPF H; LEVINE S
    Bull World Health Organ; 1955; 12(4):677-85. PubMed ID: 14379004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study of the poliomyelitis epidemic at Saint Augustin, P. Q. Canada. II. Development of the amount of antibodies neutralizing the Lansing Strain virus following the epidemic caused by Brunhilde strain virus].
    PAVILANIS V; FRAPPIER A
    Ann Inst Pasteur (Paris); 1953 Dec; 85(6):690-705. PubMed ID: 13148812
    [No Abstract]   [Full Text] [Related]  

  • 3. Serological markers for hepatitis B and treponemal infection among HIV carriers from Ethiopia.
    Alkan ML; Maayan S; Belmaker I; Arbeli Y; Mani N; Ben-Yshai F
    Isr J Med Sci; 1993; 29(6-7):390-2. PubMed ID: 8349459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies on poliomyelitis virus. III. Determination of Lansing antibodies level during disease and convalescence in Heine-Medin disease].
    PRZESMYCKI F; TAYTSCH Z; BAKOWSKA-KENCZEWA K; SEMKOW R
    Med Dosw Mikrobiol; 1953; 5(4):411-6. PubMed ID: 13132467
    [No Abstract]   [Full Text] [Related]  

  • 5. Complement-fixing antibodies to type 2 (Lansing) poliomyelitis virus in a normal population of a subtropical area.
    GOLDBLUM N; MELNICK JL
    J Exp Med; 1952 Aug; 96(2):175-85. PubMed ID: 14955573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antibodies to the Lansing strain of poliomyelitis virus in sera and colostra in Hungary].
    PINTER M
    Acta Med Acad Sci Hung; 1953; 4(1):105-10. PubMed ID: 13039943
    [No Abstract]   [Full Text] [Related]  

  • 7. [Sero-neutralizing antibodies against poliomyelitis virus II (Lansing) in inhabitants of Bucharest].
    CAJAL N; LISSIEVICI-OPRESCU E
    Stud Cercet Inframicrobiol; 1956; 7(1-2):57-63. PubMed ID: 13380643
    [No Abstract]   [Full Text] [Related]  

  • 8. Poliomyelitis outbreak in Israel, 1950-1.
    YEKUTIEL P; LEVINGER EL; MUHSAM HV; YEKUTIEL MP
    Bull World Health Organ; 1955; 12(4):651-76. PubMed ID: 14379003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Status of immunity against poliomyelitis in Germany].
    Maass G; Doerr HW
    Dtsch Med Wochenschr; 1986 Oct; 111(44):1670-6. PubMed ID: 3021426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between serum antibodies and subclinical infections with poliomyelitis virus.
    BROWN GC; AINSLIE JD
    J Exp Med; 1951 Mar; 93(3):197-205. PubMed ID: 14824395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroimmunity to poliomyelitis in Sweden after the use of inactivated poliovirus vaccine for 10 years.
    Böttiger M; Zetterberg B; Salenstedt CR
    Bull World Health Organ; 1972; 46(2):141-9. PubMed ID: 4537478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A specific complement-fixation test for infection with poliomyelitis virus.
    CASALS J; OLITSKY PK; ANSLOW RO
    J Exp Med; 1951 Aug; 94(2):123-37. PubMed ID: 14861374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies on poliomyelitis. III. Behavior of neutralizing antibodies against three types of poliomyelitis from patient and convalescent individual].
    GIOVANARDI A; MONACI V; BONETTI F
    Boll Ist Sieroter Milan; 1954; 33(3-4):219-22. PubMed ID: 13160173
    [No Abstract]   [Full Text] [Related]  

  • 14. Transplacental antibodies. Part III: Maternal antibodies against polioviruses, M. parotitidis and M. parainfluenzae.
    Celko A; Burianová B; Fedová D; Koza J; Zikmundová V; Zikmund V; Stríbrný J
    J Hyg Epidemiol Microbiol Immunol; 1985; 29(2):193-9. PubMed ID: 2991367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunity of the Croatian population to poliomyelitis--a serosurvey.
    Borcić B; Kruzić V; Kaić B; Ljubin-Sternak S; Ljubicić M; Dobrovsak-Sourek V
    Acta Med Croatica; 1998; 52(4-5):229-33. PubMed ID: 9988903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Geographical distribution of neutralizing antibody against poliomyelitis virus "Lansing" strain on human sera collected in various parts of Japan.
    KITAOKA M; MIURA T
    Jpn J Med; 1951 Aug; 4(4):215-21. PubMed ID: 14907188
    [No Abstract]   [Full Text] [Related]  

  • 17. Immune status of the population to poliovirus infection in Singapore.
    Goh KT; Yamazaki S
    Bull World Health Organ; 1987; 65(1):83-6. PubMed ID: 3034442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poliomyelitis: epidemiology and prophylaxis. 5. Results of a two- and three-dose vaccination experiment.
    Metselaar D; McDonald K; Gemert W; van Rens MM; Muller AS
    Bull World Health Organ; 1977; 55(6):755-9. PubMed ID: 202418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Passive immunity in poliomyelitis. VI. Antibody decline in Rhesus monkeys inoculated with homologous Lansing antiserum.
    WOOD W; CLARK EM; SHIMADA FT; RITCHIE RC; REID DB; RHODES AJ
    Proc Soc Exp Biol Med; 1953 Mar; 82(3):487-9. PubMed ID: 13047439
    [No Abstract]   [Full Text] [Related]  

  • 20. [The status of immunity against poliomyelitis. The 5th cooperative study of the German Union to Control Viral Diseases, Inc].
    Maass G; Weber B; Doerr HW
    Dtsch Med Wochenschr; 1991 Sep; 116(39):1457-62. PubMed ID: 1655377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.